Clinical Trials Browser

Phase NA × Terminated × Lenalidomide × Clear all

NCT01927718 2019-04-29

Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT)

Phase NA Terminated

10 enrolled 5 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01649791 2016-06-30

Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia

Phase NA Terminated

8 enrolled 9 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell